Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Idenix Caymans LtdfiledCriticalIdenix Caymans Ltd
Priority to MYPI20022967priorityCriticalpatent/MY136394A/en
Publication of MY136394ApublicationCriticalpatent/MY136394A/en
PHYSICAL FORMS OF BETA-L-2'-DEOXYTHYMIDINE ARE DISCLOSED THAT CAN BE CHARACTERIZED BY PHYSICAL APPEARANCE, PURITY LEVELS, INFRA-RED AND RAMAN SPECTROSCOPY, X-RAY POWDER DIFFRACTION PATTERNS, THERMAL PROPERTIES, AND METHODS OF MANUFACTURE. THESE FORMS OF BETA-L-2'-DEOXYTHYMIDINE CAN BE USED IN THE MANUFACTURE OF OTHER FORMS OF BETA-L-2'-DEOXYTHYMIDINE, OR IN PHARMACEUTICAL COMPOSITIONS. PARTICULARLY PREFERRED USES ARE IN THE TREATMENT OF HEPATITIS B.
MYPI200229672002-08-092002-08-09Crystalline and amorphous forms of beta-l-2'-deoxythymidine
MY136394A
(en)
Use of oxindole derivatives in the treatment of dementia related diseases, alzheimer's disease and conditions associated with glycogen synthase kinase-3